Obsessive-Compulsive Disorder: PMHNP Board Review

Obsessive-compulsive disorder (OCD) is defined by the presence of obsessions, compulsions, or both that are time-consuming (more than one hour per day) or cause clinically significant distress or impairment. The single highest-yield board point: first-line treatment is an SSRI at doses higher than those used for depression, combined with exposure and response prevention (ERP). OCD lives in its own DSM-5-TR chapter, Obsessive-Compulsive and Related Disorders — it is no longer classified as an anxiety disorder.

This review walks through the criteria, differential, treatment hierarchy, and the exam traps that catch test-takers.

Epidemiology and onset

OCD affects roughly 1–2% of the population, with a typical bimodal onset — one peak in childhood/early adolescence (more common in males) and another in early adulthood (slight female predominance). Onset after age 35 is unusual and should prompt a search for a neurologic or medical contributor. The course is usually chronic with waxing and waning symptoms, and most patients wait years before seeking treatment because of shame, especially with taboo obsessions. There is a strong familial/genetic component, and dysregulation of the cortico-striato-thalamo-cortical (CSTC) circuitry and the serotonin system underlies the disorder — which explains why serotonergic agents, not noradrenergic ones, are effective. Recognizing the chronic, relapsing nature is important because patients often need long-term maintenance pharmacotherapy and may relapse if medication is stopped prematurely.

Diagnostic criteria (DSM-5-TR)

The core of OCD is obsessions and/or compulsions. You must be able to define both.

• Obsessions: Recurrent, persistent, intrusive thoughts, urges, or images that are unwanted and cause marked anxiety or distress. The person attempts to ignore, suppress, or neutralize them.

• Compulsions: Repetitive behaviors (handwashing, checking, ordering) or mental acts (counting, praying, repeating words) performed in response to an obsession or according to rigid rules. They are aimed at reducing distress or preventing a feared event but are not realistically connected to what they neutralize, or are clearly excessive.

Full criteria require that the obsessions/compulsions are time-consuming (>1 hour/day) or cause distress/impairment, are not attributable to a substance or medical condition, and are not better explained by another disorder.

Insight specifiers — a favorite testable point

• With good or fair insight: The person recognizes OCD beliefs are probably or definitely not true.

• With poor insight: Thinks the beliefs are probably true.

• With absent insight/delusional beliefs: Completely convinced the beliefs are true. Importantly, this is still OCD — not a psychotic disorder. The exam loves to disguise delusional-insight OCD as psychosis.

Also note the tic-related specifier (current or past tic disorder), which is associated with earlier onset and a different treatment-response profile.

Clinical features and differential

Common symptom dimensions include contamination/washing, harm/checking, symmetry/ordering, and taboo intrusive thoughts (aggressive, sexual, religious). Patients with taboo obsessions are often deeply distressed and ashamed; recognizing that ego-dystonic intrusive thoughts are a hallmark of OCD, not intent to act, is high-yield and reassuring to patients.

Key differentials to distinguish:

• Generalized anxiety disorder: Worries are about real-life concerns and are ego-syntonic; OCD obsessions are intrusive, irrational, and resisted.

• Obsessive-compulsive personality disorder (OCPD): A pervasive pattern of perfectionism and control that is ego-syntonic — no true obsessions or compulsions. OCPD vs OCD is a classic board distinction.

• Body dysmorphic disorder, hoarding disorder, trichotillomania, excoriation disorder: All OC-related disorders in the same DSM-5-TR chapter.

• Psychotic disorders: Differentiated by the presence of other psychotic symptoms and the absence of compulsions; remember absent-insight OCD is not psychosis.

• Tourette/tic disorders: Frequently comorbid; tics are not goal-directed in the way compulsions are.

In children, consider PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) when OCD or tics appear abruptly after a strep infection.

Common comorbidities

OCD rarely travels alone, and comorbidity drives many clinical-vignette questions. The most common companions are major depressive disorder, anxiety disorders, and tic disorders. Depression is present in a large share of patients and may be the reason they finally present for care; always screen for suicidality, as it raises overall risk. OCD also co-occurs with other obsessive-compulsive related disorders (body dysmorphic disorder, hoarding disorder, hair-pulling, skin-picking) and, less commonly, with eating disorders and ASD. When OCD coexists with bipolar disorder, antidepressant monotherapy can risk a mood switch, so a stem describing manic symptoms after starting an SSRI is testing your awareness of that interaction. Sorting the primary diagnosis from comorbid distractors is a recurring board skill.

First-line treatment

Pharmacotherapy

• SSRIs are first-line and the most testable answer. All SSRIs are considered roughly equally effective. FDA-approved options include fluoxetine, fluvoxamine, sertraline, and paroxetine.

• Use higher doses than for depression. OCD often requires the upper end of the dosing range (for example, fluoxetine 60–80 mg, sertraline 200 mg). This is one of the most reliably tested facts in OCD pharmacology.

• Allow a longer trial. Response can take 8–12 weeks at adequate dose, longer than the 4–6 weeks expected in depression. Do not declare treatment failure prematurely.

• Clomipramine is a tricyclic antidepressant with potent serotonin reuptake inhibition and is highly effective for OCD. It is generally reserved for after SSRI failures because of anticholinergic effects, cardiac/QTc risk, seizure risk at high doses, and lethality in overdose. When a question describes treatment-resistant OCD after multiple SSRIs, clomipramine is often the intended next step.

• Augmentation: For partial response, low-dose antipsychotics (e.g., aripiprazole, risperidone) can be added — especially useful in tic-related OCD. See our overview of antipsychotic side effects before initiating.

Psychotherapy

• Exposure and response prevention (ERP) is the gold-standard, first-line psychotherapy. The patient is exposed to the feared stimulus while preventing the compulsive response, which extinguishes the anxiety-relief cycle. ERP is a specialized form of CBT, and on the boards "ERP" or "CBT with ERP" is the correct behavioral answer.

• Combining ERP with an SSRI is more effective than either alone for moderate-to-severe OCD.

• Standard supportive psychotherapy, relaxation training, and generic insight-oriented therapy are not evidence-based first-line treatments for OCD and frequently appear as distractors. The behavioral mechanism — habituation and extinction through prevented compulsions — is what makes ERP uniquely effective.

Treatment-resistant OCD and special situations

When a patient fails an adequate trial (maximally tolerated SSRI dose for 8–12 weeks) plus ERP, the next steps are switching to a different SSRI, switching to clomipramine, or augmenting with a low-dose antipsychotic. Roughly 40–60% of patients respond to first-line SSRIs, so partial and non-response are common board scenarios. For severe, refractory OCD that has not responded to multiple medication trials and ERP, more intensive options exist, including intensive outpatient/residential ERP programs and, rarely, neurosurgical or neuromodulation approaches (deep brain stimulation, transcranial magnetic stimulation). These advanced options are typically the "last resort" answer rather than an early step. For maintenance, medication is usually continued for at least 1–2 years after response given the high relapse rate, and any taper should be gradual.

For pharmacology fundamentals that recur across anxiety and OC-related disorders, review our PMHNP psychopharmacology high-yield guide.

High-yield board pearls

• Higher SSRI doses, longer trials. If a stem describes inadequate response at a depression-level dose after only a few weeks, the answer is usually increase the dose and extend the trial, not switch agents.

• ERP is the specific behavioral therapy — generic "supportive therapy" or relaxation training is a distractor.

• Clomipramine is the most effective single agent but not first-line due to its side-effect burden.

• Absent-insight OCD is still OCD. Do not jump to an antipsychotic-only psychosis answer.

• OCPD is ego-syntonic and has no true obsessions/compulsions.

• Consider PANDAS for abrupt childhood-onset OCD after streptococcal infection.

• Watch for comorbid depression and suicidality, which are common and may shift management priorities.

Common exam traps

• Confusing OCD with OCPD. The personality disorder is a pattern of rigidity and perfectionism that the person sees as reasonable; OCD symptoms are distressing and resisted.

• Underdosing the SSRI. Choosing to abandon an SSRI that simply wasn't pushed to OCD-level doses for a long-enough trial.

• Calling delusional-insight OCD a psychotic disorder. The presence of compulsions and the absence of other psychotic features keeps it in the OCD category.

• Mistaking taboo intrusive thoughts for risk. Ego-dystonic aggressive or sexual obsessions reflect distress, not intent — recognizing this is both clinically and ethically tested.

• Picking benzodiazepines. They are not a first-line treatment for OCD and do not address the obsessive-compulsive cycle.

All clinical decisions should be guided by current practice guidelines and an individualized risk-benefit assessment; this review summarizes board-level concepts rather than prescribing direction for a specific patient.

Keep building your board readiness

OCD is a reliable source of exam questions because it rewards precise knowledge of dosing, therapy type, and the OCD-vs-OCPD distinction. Reinforce these patterns with active recall and timed practice. Explore the full PMHNP question bank and study tools, take a quick diagnostic assessment to find your weak areas, or create a free account to start drilling board-style OCD and OC-related disorder questions today.